欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 肿瘤标志抗原
肿瘤标志抗原

Anti-CIP2A [HL1925](MABL-3913)

简要描述:

Engineer antibody

产品参数:

Cat. No.:MABL-3913

Application:IHC (P), WB

Isotype:Engineer antibody

Species Reactivity:Human

Clone No.:HL1925

产品价格:¥0

详细介绍
Cat. No.
MABL-3913
Application
IHC (P), WB
Isotype
Engineer antibody
Species Reactivity
Human
Clone No.
HL1925
From
Recombinant Antibody
Specificity
This antibody binds human CIP2A (cancerous inhibitor of protein phosphatase 2A). CIP2A is an oncoprotein that inhibits protein phosphatase 2A (PP2A), stabilizes MYC, and is involved in the progression of several human malignancies. It promotes anchorage-independent cell growth and tumor formation.Antibodies against CIP2A are present in sera from many patients with gastric or prostate cancer and acts as prognostic marker in many cancers.
Alternative Names
Cancerous inhibitor of protein phosphatase 2A; Cancerous inhibitor of PP2A; Protein CIP2A; p90 autoantigen; KIAA1524
UniProt
Q8TCG1
Immunogen
The original monoclonal antibody was generated by collecting spleen cells from an immunized mouse, followed by an affinty purification on a goat anti-CSAp IgG column and susequent fusion with the nonsecreting mouse myeloma cell line SP2/0-Agl4.
Application Notes
This antibody binds a single site epitope of the CSAp and has an afiinity constant Ka =9.61 x 108/mol. This antibody is not suitable for sandwich ELISA as it binds to a single site epitope of the CSAp, it is however suitable for direct and competition ELISA. This antibody does not react with reduced and alkylated CSAp. This antibody cannot fully block the reactivity of goat anti-CSAp. Immunohistochemical staining of neoplastic tissues showed the Mu-9-reactive determinant to be present in 60% of colon carcinomas. This antibody showed no reactivity outside the intestinal tract and no reactivity with blood cells (PMID: 2169346). The comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies effects of antibodies, Mu-9 and NP-4 IgG (anti-CEA antibody) revealed that even though the anti tumor effects of both these antibodies are equal, there is a significant difference in their therapeutic effectiveness (PMID: 2759735). Radioimmunotherapy of GW-39 human colonic tumor xenografts grown in the hamster cheek pouch with131I-labeled NP-4 anti-(carcinoembryonic antigen) (CEA) and131I-labeled Mu- 9 anti-(color-specific antigen-p) (CSAp) murine monoclonal antibodies, administered in combination, was more effective than using either antibody alone for tumor masses less than 0.5 cm3 in size (PMID: 1652355).
Antibody First Published
Gold et al. Murine Monoclonal Antibodies to Colon-specific Antigen p. Cancer Research (1990) ; Vol : 50; 6405-6409. PMID:2169346
Note on publication
Describes the generation of antibody.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.

 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号